Neuren Pharmaceuticals Limited’s (NEU) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting Neuren Pharmaceuticals Limited is a Sell.

Neuren Pharmaceuticals Limited’s (NEU) 20-Day exponential moving average is 12.31, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.2, making it a Buy.

Neuren Pharmaceuticals Limited’s (NEU) 50-Day exponential moving average is 12.84, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.2, making it a Buy.

Neuren Pharmaceuticals Limited (NEU) Pivot Points

Jan 19, 2025, 03:13 AM

Classic

10.81

11.11

11.69

11.99

12.57

12.87

13.45

Fibonacci

11.11

11.44

11.65

11.99

12.32

12.53

12.87

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neuren Pharmaceuticals Limited (NEU) Moving Averages

Jan 19, 2025, 03:13 AM

MA5

12.07Buy

12.32Buy

MA10

12.07Buy

12.20Buy

MA20

12.21Buy

12.31Buy

MA50

13.21Sell

12.84Buy

MA100

13.40Sell

13.87Sell

MA200

16.41Sell

16.30Sell

Neuren Pharmaceuticals Limited’s (NEU) 10-Day exponential moving average is 12.20, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.2, making it a Buy.

Neuren Pharmaceuticals Limited’s (NEU) 100-Day exponential moving average is 13.87, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.2, making it a Sell.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.2 and Neuren Pharmaceuticals Limited’s (NEU) 50-day simple moving average is 13.21, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.2 and Neuren Pharmaceuticals Limited’s (NEU) 100-day simple moving average is 13.40, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.2 and Neuren Pharmaceuticals Limited’s (NEU) 200-day simple moving average is 16.41, creating a Sell signal.

Neuren Pharmaceuticals Limited (NEU) Technical Indicators

Jan 19, 2025, 03:13 AM

RSI (14)

57.32

Neutral

STOCH (9,6)

63.05

Neutral

STOCHRSI (14)

61.03

Neutral

MACD (12,26)

-0.21

Sell

ADX (14)

17.55

Buy

Williams %R

-4.56

Sell

CCI (14)

207.82

Sell

ATR (14)

0.60

Ultimate Oscillator

53.25

Neutral

ROC

6.97

Buy

Neuren Pharmaceuticals Limited’s (NEU) Relative Strength Index (RSI) is 57.32, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NEU) Trend Strength Indicator (ADX) is 17.55, creating a Buy signal.

Neuren Pharmaceuticals Limited’s (NEU) Commodity Channel Index (CCI) is 207.82, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NEU) Price Rate of Change (ROC) is 6.97, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NEU a Buy, Hold, or Sell?

Based on NEU’s technical indicators, NEU is a Hold.

What is NEU’s RSI (14)?

NEU’s RSI (14) is 57.32, which suggests NEU is a Neutral.

What is NEU’s MACD?

NEU’s MACD is -0.21, which suggests NEU is a Sell.

What is NEU’s 5-day moving average?

NEU’s 5-day moving average is 12.07, which suggests NEU is a Buy.

What is NEU’s 20-day moving average?

NEU 20-day moving average is 12.21, which suggests NEU is a Buy.

What is NEU’s 50-day moving average?

NEU’s 50-day moving average is 13.21, which suggests NEU is a Sell.

What is NEU’s 200-day moving average?

NEU’s 200-day moving average is 16.41, which suggests NEU is a Sell.

What is NEU’s Williams % R (14)?

NEU’s Williams % R (14) is -4.56, which suggests NEU is a Sell.

What is NEU’s CCI (14)?

NEU’s CCI (14) is 207.82, which suggests NEU is a Sell.

What is the share price of Neuren Pharmaceuticals Limited?

Neuren Pharmaceuticals Limited's share price is N/AAU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing